The 2021 edition, adopted on 31 December 2020 and in force from 1 January 2021; the anti-doping rules were rewritten on the basis of the 2021 World Anti-Doping Code and delegation of implementation to a third party was recognised.
| Adoption | 31 December 2020 — FIVB Board of Administration |
| In force from | 1 January 2021 |
| Structure | Medical section + anti-doping rules aligned with the 2021 Code |
| Status | Superseded — replaced by the June 2023 version |
The Medical and Anti-Doping Regulations of the Fédération Internationale de Volleyball (FIVB) bring two documents together in a single text: the medical rules for events — including the injury reporting procedure — and the anti-doping rules, which implement the World Anti-Doping Code in volleyball. The FIVB may delegate part or all of doping control to a third party such as the International Testing Agency (ITA), and hearings and results management to the Anti-Doping Division of the Court of Arbitration for Sport, but responsibility for compliance remains its own.
Every doping case involving a volleyball player is determined on the basis of this text. The decisive point in the defence: liability is strict, and establishing a violation requires no proof of intent, fault or negligence on the athlete's part. The medical regulations are likewise binding on the team physician and the federation at international events.